Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

por Goto, Takeyuki, Tani, Naoki, Ikematsu, Hideyuki, Gondo, Kei, Oishi, Ryo, Minami, Junya, Onozawa, Kyoko, Kuwano, Hiroyuki, Akashi, Koichi, Shimono, Nobuyuki, Chong, Yong
Publicado 2022

Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine

por Tani, Naoki, Chong, Yong, Kurata, Yasuo, Gondo, Kei, Oishi, Ryo, Goto, Takeyuki, Minami, Junya, Onozawa, Kyoko, Nagano, Sukehisa, Shimono, Nobuyuki, Ikematsu, Hideyuki, Kuwano, Hiroyuki
Publicado 2022

No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19

por Tani, Naoki, Ikematsu, Hideyuki, Goto, Takeyuki, Gondo, Kei, Yanagihara, Yuki, Kurata, Yasuo, Oishi, Ryo, Minami, Junya, Onozawa, Kyoko, Nagano, Sukehisa, Kuwano, Hiroyuki, Akashi, Koichi, Shimono, Nobuyuki, Chong, Yong
Publicado 2022

Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic...

por Tani, Naoki, Ikematsu, Hideyuki, Goto, Takeyuki, Gondo, Kei, Inoue, Takeru, Yanagihara, Yuki, Kurata, Yasuo, Oishi, Ryo, Minami, Junya, Onozawa, Kyoko, Nagano, Sukehisa, Kuwano, Hiroyuki, Akashi, Koichi, Shimono, Nobuyuki, Chong, Yong
Publicado 2022